Rittenhouse Ventures

Founder and Managing Partner Saul Richter leads the investment team alongside General Partners David Nevas and Sushma Rajagopalan. The six-person team operates from Wayne, Pennsylvania, and sources deals collectively, with each partner drawing on domain expertise in B2B technology and healthcare services.

While the firm is Philadelphia-based and concentrates sourcing in the Mid-Atlantic and Northeast, its portfolio spans the U.S. Active investments are located in New Jersey, New York, Massachusetts, and Texas, reflecting a willingness to back companies beyond its immediate geography when the sector fit is strong.

Rittenhouse invests across early-stage, expansion, and late-stage rounds, with a lean toward companies that have already demonstrated product-market fit in B2B technology or healthcare. The firm's staging philosophy means it often leads or participates in rounds sized to fund a specific growth milestone rather than a maximum raise.

The firm's team page and investment announcements reference strategic and regional investor partnerships, but Rittenhouse does not describe a formal co-investment club or syndicate model. Co-investment opportunities appear to be evaluated on a deal-by-deal basis alongside the firm's own fund commitments.